TRODELVY

gilead sciences canada inc🇨🇦 Health Canada

Approval Id: a51ab79be2f41870
Drug Approval Canada Name: TRODELVY
Product Name: TRODELVY
Status: Marketed
Status Date: 2021-11-22
Original Market Date: 2021-11-22
Din: 02520788
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Schedule D , Prescription
Ahfs: 10:00.00
Atc Original: L01FX17 SACITUZUMAB GOVITECAN
Atc Name: l 01 fx 17
Aig Number: 0163175001
Company Name: gilead sciences canada inc
Company Address: 400, 6925 Century Avenue, Mississauga, Ontario, Canada, L5N 7K2

SACITUZUMAB GOVITECAN

180 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a51ab79be2f41870

Type

Standard